Venture Logo

In-Med Prognostics

Healthcare Technology

InMed AI, also known as InMed Prognostics, is a pioneering company in the field of AI-driven predictive analytics, focusing on multi-modal data including text, signal, and image. A significant achievement of InMed AI is the development of NeuroShield™, the world's only US FDA 510 K approved AI-powered MR volumetric solution. This tool is noteworthy for its ability to provide reference ranges adjusted to age, gender, and ethnicity, thereby contributing to precision medicine. The company's mission revolves around making healthcare tools that are affordable, accessible, reliable, and state-of-the-art, available to everyone globally. This mission is driven by a commitment to address the needs of traditionally underserved and underrepresented populations in both the global north and south markets. InMed AI's focus is on extending the quality of life through technology, and it has a particular emphasis on inclusion and ethnicity in healthcare. NeuroShield™ plays a critical role in the early detection of atrophy in patients suffering from neurodegenerative disorders, which is crucial for the effective use of newly developed pharmaceuticals. InMed AI's expertise also extends to building and deploying tools for remote site monitoring and medical imaging data visualization, applicable in various clinical and research settings. They are actively expanding their product suites to include applications in CT Brain, Whole Body MRI/Video Wellness/Athletic solutions, and lesion solutions for pancreatic and liver cancer.

PRODUCTS

NeuroShield, NeuroFlo, VivoShield Sports

SERVICES

Whole Body Analysis, Body Mass Analysis, Tissue Type Distribution Analysis, Targeted Body Part Analysis, Brain Assessment, Digital Physical Exams and Health Assessments

KEY PERSONAL

Placeholder Image
Dr. Latha Poonamallee

Serves as the Founder & CEO and holds a Ph.D. from Case Western Reserve University in Cleveland, Ohio.

Placeholder Image
Dr. Al Curran

Co-Founder with a Ph.D. from Stanford University.

Placeholder Image
Rajesh Purushottam

Co-founder at In-Med Prognostics

KEYWORDS

AI-powered healthcare and wellness tools, Neuroshield, NeuroFlo, VivoShield, Predictive and Preventative Mental Health, Ethnicity-specific reports, Precision and Personalised Medicine, Neurology workflow platform, Brain volumes analysis, Advanced research and human-centred design

KEY PERSONAL

Placeholder Image
Dr. Latha Poonamallee

Serves as the Founder & CEO and holds a Ph.D. from Case Western Reserve University in Cleveland, Ohio.

Placeholder Image
Dr. Al Curran

Co-Founder with a Ph.D. from Stanford University.

Placeholder Image
Rajesh Purushottam

Co-founder at In-Med Prognostics

No data Available

No data Available

LOCATION

300, NCL Innovation Park, Dr. Homi Bhabha Road, NCL Colony, Pashan, Pune, Maharashtra, India - 411028

INCORPORATION DATE

10 January 2018

STATE/CITY

Pune, Maharashtra

© Health Tech Directory. All Rights Reserved. Developed by Mocero Health Solutions.

Powered by Mocero Health Solutions.